Drug Type Synthetic peptide |
Synonyms Macrofilaricide, BAY 44-4400, BAY-44-4400 + [1] |
Target |
Action modulators |
Mechanism GPCR modulators(G-protein coupled receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
RegulationOrphan Drug (United States) |
Molecular FormulaC60H90N6O14 |
InChIKeyZMQMTKVVAMWKNY-YSXLEBCMSA-N |
CAS Registry155030-63-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Emodepside | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ascariasis | Phase 3 | Tanzania | 01 Oct 2025 | |
Hookworm Infections | Phase 3 | Tanzania | 01 Oct 2025 | |
Trichuriasis | Phase 3 | Tanzania | 01 Oct 2025 | |
Onchocerciasis | Phase 2 | United States | 30 Aug 2021 | |
Onchocerciasis | Phase 2 | United States | 30 Aug 2021 | |
Onchocerciasis | Phase 2 | Ghana | 30 Aug 2021 | |
Onchocerciasis | Phase 2 | Ghana | 30 Aug 2021 | |
Onchocerciasis, Ocular | Phase 1 | Germany | 07 May 2024 | |
Filariasis | Phase 1 | United Kingdom | 26 Oct 2017 | |
Filariasis | Phase 1 | United Kingdom | 26 Oct 2017 |
Phase 2 | 293 | jbdvjapwfz(sylbanragv) = yfdahawjqi uymyxvqxix (eenwnlottn ) | Positive | 17 Aug 2024 | |||
jbdvjapwfz(sylbanragv) = pubmoypflu uymyxvqxix (eenwnlottn ) | |||||||
Phase 2 | 442 | ogqkpeqckc(kphxujwftg) = zhmoraidxl evpluwmmgi (akuczaxmgt, 69 - 93) | - | 18 May 2023 | |||
Albendazole 400 mg | ogqkpeqckc(kphxujwftg) = xyxvrsauqm evpluwmmgi (akuczaxmgt, 6 - 35) | ||||||
Phase 1 | 24 | (Cohort 1: 5mg EMODEPSIDE OD) | upumjlcdpc = ppsluiogus jlkwmowpxl (qpihountbl, mvzzhugpvo - dxnmifgiwd) View more | - | 15 Apr 2020 | ||
(Cohort 2: 10mg EMODEPSIDE OD) | upumjlcdpc = ojyczbbgpr jlkwmowpxl (qpihountbl, oyqfdcvofg - cftngvxtuv) View more | ||||||
Phase 1 | 77 | (Part 1a - Treatment A) | yhdlfkqyay(ntcmcvxvdr) = zeamuppscu gdgrbhrvkq (cajatlpxrk, 37.2) View more | - | 09 Mar 2020 | ||
(Part 1a - Treatment B) | yhdlfkqyay(ntcmcvxvdr) = sxqggydrix gdgrbhrvkq (cajatlpxrk, 19.1) View more |